Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | DCPS | Q96C86 | 3/20 | 0.35 |
| ▸ | NCF1 | P14598 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL618693 | 0.89 | NUDT1 (0.40) | KMT2AMEN1TP53HSD17B10DCPS | |
| SCHEMBL619884 | 0.86 | KMT2A (0.42) | KMT2AMEN1TP53HSD17B10DCPS | |
| SCHEMBL621083 | 0.85 | KMT2A (0.41) | KMT2AMEN1TP53HSD17B10DCPS | |
| SCHEMBL12266852 | 0.84 | KMT2A (0.41) | KMT2AMEN1TP53HSD17B10DCPS | |
| Hydrochloric Acid SCHEMBL618867 | 0.84 | KMT2A (0.41) | KMT2AMEN1TP53HSD17B10DCPS | |
| Hydrochloric Acid SCHEMBL618868 | 0.84 | KMT2A (0.41) | KMT2AMEN1TP53HSD17B10DCPS | |
| SCHEMBL10257881 | 0.83 | KMT2A (0.39) | KMT2AMEN1TP53HSD17B10DCPS | |
| SCHEMBL620706 | 0.80 | KMT2A (0.40) | KMT2AMEN1TP53HSD17B10DCPS | |
| SCHEMBL10257493 | 0.80 | KMT2A (0.40) | KMT2AMEN1TP53HSD17B10DCPS | |
| SCHEMBL624315 | 0.80 | MEN1 (0.36) | KMT2AMEN1TP53HSD17B10DCPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150245642-A1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED | 2015-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150245642-A1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | TFEB, TREH, SLC2A8 | KMT2A 740/4885MEN1 2269/4885TP53 2058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.